Symbiotec Pharmalab Limited (NSE:SYMBIOTEC)
India · Delayed Price · Currency is INR 1,120.00
+41.75 (3.87%)
Last updated: Sep 7, 2026, 10:55 AM IST
Symbiotec Pharmalab Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1,099 | 967.84 | 1,002 | 234.86 | 775.27 |
Depreciation & Amortization | 532.83 | 431.01 | 388.22 | 285.22 | 258.28 |
Loss (Gain) From Sale of Assets | -1.19 | 2.73 | -0.07 | -0.25 | 0.61 |
Asset Writedown & Restructuring Costs | - | - | - | - | 3.11 |
Loss (Gain) From Sale of Investments | - | 10.1 | - | -0.03 | -0.06 |
Loss (Gain) on Equity Investments | - | 1.55 | 13.66 | 10.75 | -2.4 |
Stock-Based Compensation | 97.46 | 42.93 | - | - | - |
Provision & Write-off of Bad Debts | - | - | - | -6.67 | 7.92 |
Other Operating Activities | 42.73 | 284.3 | -25.22 | 28.21 | -16.74 |
Change in Accounts Receivable | -593.67 | -719.78 | -301.2 | 182.15 | -221.86 |
Change in Inventory | 245.71 | 743.35 | -920.13 | 18.86 | -200.14 |
Change in Accounts Payable | 215.43 | -1,315 | 1,699 | -74.45 | -438.48 |
Change in Other Net Operating Assets | 107.81 | 23.36 | 18.8 | 13.73 | 11.6 |
Operating Cash Flow | 1,746 | 472.56 | 1,875 | 692.38 | 177.11 |
Operating Cash Flow Growth | 269.46% | -74.80% | 170.81% | 290.93% | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -2,257 | -3,081 | -2,098 | -2,244 | -723.5 |
Sale of Property, Plant & Equipment | 13.2 | - | 0.44 | 0.85 | 0.04 |
Investment in Securities | -28.75 | 8.48 | -27.32 | 28.67 | 396.3 |
Other Investing Activities | 3.44 | 7.49 | 60.53 | 14.52 | 10.72 |
Investing Cash Flow | -2,269 | -3,065 | -2,064 | -2,200 | -316.44 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | 572.07 | 1,784 | - | 419.52 | 179.63 |
Long-Term Debt Issued | 253.21 | 1,306 | 845.98 | 1,113 | - |
Total Debt Issued | 825.28 | 3,089 | 845.98 | 1,532 | 179.63 |
Short-Term Debt Repaid | - | - | -549.79 | - | - |
Long-Term Debt Repaid | -2,383 | -152.07 | -4.48 | -1.7 | -8.39 |
Lease Payments | -9.1 | -2.43 | -1.58 | -1.7 | -1.1 |
Total Debt Repaid | -2,383 | -152.07 | -554.27 | -1.7 | -8.39 |
Net Debt Issued (Repaid) | -1,558 | 2,937 | 291.71 | 1,531 | 171.24 |
Issuance of Common Stock | 2,182 | - | - | - | - |
Other Financing Activities | -263.99 | -155.62 | -73.23 | -69.12 | -19.84 |
Financing Cash Flow | 359.87 | 2,782 | 218.48 | 1,461 | 151.4 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | -163.5 | 188.95 | 29.44 | -46.11 | 12.07 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -511.26 | -2,609 | -222.69 | -1,552 | -546.39 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -5.88% | -34.71% | -3.11% | -27.39% | -8.01% |
Free Cash Flow Per Share | -8.84 | -46.78 | -4.00 | -28.37 | -9.99 |
Levered Free Cash Flow | -465.47 | -2,495 | -202.58 | -1,530 | - |
Unlevered Free Cash Flow | -315.27 | -2,407 | -166.67 | -1,496 | - |
Free Cash Flow After Leases | -520.36 | -2,611 | -224.27 | -1,553 | -547.49 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 263.99 | 155.62 | 73.23 | 69.12 | 19.84 |
Cash Income Tax Paid | 617.11 | 348.27 | 342.71 | 166.64 | 297.55 |
Change in Working Capital | -24.72 | -1,268 | 496.68 | 140.29 | -848.88 |